Skip to main content
. Author manuscript; available in PMC: 2013 Feb 26.
Published in final edited form as: Hypertension. 2007 Jun 25;50(2):392–395. doi: 10.1161/HYPERTENSIONAHA.107.092197

Table 3. LV Abnormalities by Casual BP and ABPM.

LV Abnormality/Associated OR Normal BP (n=35) White-Coat HTN (n=32) Masked HTN (n=9) Stage 1 HTN (n=50) Stage 2 HTN (n=34) P
LVMI, g/m2.7 33.8±10.81 35.8±13.15 42.3±11.51 39.7±13.07 41.1 ±17.36 0.11*
LVH prevalence, % 5.7 9.4 22.2 18.0 32.4 <0.01†
Crude OR (95% CI) 1.0 (reference) 1.71 (0.27 to 10.94) (0.56 to 39.39) 3.62 (0.73 to 17.92) 7.89 (1.60 to 39.01)
Adjusted OR (95% CI)‡ 1.0 1.30 (0.17 to 9.79) 6.43 (0.61 to 67.62) 2.68 (0.47 to 17.49) 7.23 (1.28 to 40.68)
*

ANOVA.

†

Nonparametric test for trend across ordered groups.

‡

Adjusted for age, gender, race/ethnicity, and BMI.